申请人:Bayer Aktiengesellschaft
公开号:US04818748A1
公开(公告)日:1989-04-04
Anti-hypertensive compounds of the formula ##STR1## in which A represents hydrogen, C.sub.1 -C.sub.8 -alkyl, C.sub.7 -C.sub.14 -aralkyl, phenylsulphonyl, tolylsulphonyl or C.sub.1 -C.sub.8 -alkylsulfphonyl, or represents an aminoprotective group, B represents a direct bond, or represents sarcosyl, or represents a group of the formula ##STR2## D represents a direct bond, or represents a group of the formula ##STR3## wherein X represents methylene, ethylene or sulphur, E, G, J, K, L and M independently have the same meanings as B, R.sup.1 is an optionally substituted phenyl radical, and Q is a hydroxy, alkoxy or amino group, or a physiologically acceptable salt thereof.
式子为##STR1##的降压化合物,其中A代表氢、C.sub.1-C.sub.8-烷基、C.sub.7-C.sub.14-芳基烷基、苯磺酰基、甲苯磺酰基或C.sub.1-C.sub.8-烷基磺酰基,或代表氨基保护基,B代表直接键,或代表肉毒碱,或代表式子##STR2##的基团,D代表直接键,或代表式子##STR3##的基团,其中X代表亚甲基、乙烯基或硫,E、G、J、K、L和M独立地具有与B相同的含义,R.sup.1是可选择取代的苯基基团,Q是羟基、烷氧基或氨基基团,或其生理学上可接受的盐。